Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer.

Saved in:

Bibliographic Details
Title:	Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer.
Authors:	Palmieri C; Department of Medical Oncology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool and Merseyside Academic Unit, Cancer Services, Royal Liverpool University Hospital, Liverpool, United Kingdom; Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom. Electronic address: c.palmieri@liverpool.ac.uk., Misra V; The Christie NHS Foundation Trust, Manchester, United Kingdom., Januszewski A; Department of Medical Oncology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Yosef H; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Ashford R; Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom., Keary I; Strategen Limited, Basingstoke, United Kingdom., Davidson N; Helen Rollason Cancer Charity, Chelmsford, Essex, United Kingdom.
Source:	Clinical breast cancer [Clin Breast Cancer] 2014 Apr; Vol. 14 (2), pp. 85-93. Date of Electronic Publication: 2013 Oct 27.
Publication Type:	Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1938-0666
DOI:	10.1016/j.clbc.2013.10.011